“And we don't expect to see the funnel convert into orders in any meaningful way here in 2024. We view that more as a 2025 event that people are waiting for their shovel-ready projects to receive funding.”

In context

“y way to quantify when you say China code activity has picked up, is that above trend versus historical averages above trend, any framework would be helpful? Rainer M. Blair: Sure. Well, in China, what we're seeing is increased activity levels in our funnel. So the volumes that we see in our funnel has been growing and that's all related to people in the market getting ready for this stimulus funding, if you will, with sort of shovel-ready projects. But what we're also seeing is a decrease in the funnel velocity as naturally market players are looking to see what the financing terms and conditions for the stimulus are. So we have watched this development. This is expected for us. This is not new news. We expected that the market would hold up to see what the funding alternatives would be. And we don't expect to see the funnel convert into orders in any meaningful way here in 2024. We view that more as a 2025 event that people are waiting for their shovel-ready projects to receive funding. Vijay Kumar: Understood, thanks guys. Rainer M. Blair: Thanks Vijay. Operator: Thank you. Our next question will come from Michael Ryskin with Bank of America. Please go ahead. Michael Ryskin: Great, thanks for taking the questions. I want to ask on Life Sciences segment. I think you flagged instruments still down high single digits. And that's a small part of the business, but it still seems like Life Sciences as a whole isn't seeing a lot of improvement yet. You also called out NGS, I think being a little bit weaker. So some parts of consumables are impacted. So just as a whole for Life Sciences, both instruments and consumables, can you dive a little bit more in terms of what you're seeing in the end market, any improvement in order trends there, just how should we expect the second ha”